MS4A1 and myeloid sarcoma: Indeed, CD20+ T cell frequency, both in the CSF and peripheral blood, was similar between eight patients with other non-inflammatory neurological disorders (OND, defined by the absence of all the following: pleocytosis, disturbance of BBB permeability, and intrathecal IgG production) and six MS patients on relapse [5].